Fetal and neonatal monitoring is a very crucial part during and after delivery of the child. During this monitoring procedure the vital physiological parameters of the child and mother are checked continuously even during delivery of the child. Heart rate, oxygen content, pulse rate, temperate, and other vital signs are monitored during this process. Moreover, increasing child mortality rate has spurred growth of the fetal and neonatal monitoring market.

Furthermore, increasing technological developments is expected to drive demand for fetal and neonatal monitoring system. For instance, MonBaby, a neonatal monitor developed by MonDevices is a small wearable, which can be clipped onto an infant’s clothing. It is designed to keep a continuous watch on an infant’s movement, it can also monitor breathing activity and body temperature. The device is very easy to use and can be attached onto any clothing of the infant. The data is synced with a mobile device through a companion mobile application.

Market Dynamics

The increasing product launches, research & developments, and funding are expected to boost the fetal and neonatal monitoring market over the forecast period. For instance, in November 2017, Bloomlife, a women health technology company received two grants from governmental organizations accounting for US$ 2.3 million that will be used to fund a longitudinal study of its remote fetal monitoring wearable and also to implement more technological advancements in the product. These grants allowed the company to further develop and validate prenatal wearable platform for labour detection (preterm and term birth) and remote fetal monitoring, the two areas of critical concern especially for high health risk in some mothers.

However, the fetal and neonatal monitoring market growth is expected to be hampered over the forecast period, owing to product recalls by the regulatory bodies. For instance, in September 2019, Ultrasound Transducer (M2736A) by Pacific Medical Group Inc. was recalled by the U.S. FDA, owing to usage of unverified or invalidated parts in the device. The possible adverse clinical impacts can be inability to accurately detect and measure fetal heart rate, inability to accurately detect maternal peripheral oxygen saturation, inability to monitor uterine activity to follow contractions, inability to determine temperature, and maternal blood pressure. The company initiated the recall but not all products were corrected or removed.

Key features of the study

• This report provides in-depth analysis of the fetal and neonatal monitoring market, market size (US$ Mn), and Compound Annual Growth Rate (CAGR (%)) for the forecast period: 2026-2033, considering 2025 as the base year
• It elucidates potential revenue opportunity across different segments and explains an attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by leading players
• It profiles key players in the global fetal and neonatal monitoring market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
• Key players covered as a part of this study include Becton, Dickinson and Company, Fujifilm SonoSite Inc., Medtronic Plc, Dragerwerk AG & Co. KGAA, Cooper Surgical, Getinge AB, Natus Medical Incorporated, GE Healthcare, Siemens Healthcare GmbH, ArjoHuntleigh, Inc., Neoventa Medical, Koninklijke Philips N.V., Analogic Corporation, Spacelabs Healthcare Inc., Smiths Medical, and Masimo.
• Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launches, government initiatives, technological upgradation, market expansion, and marketing tactics
• The global fetal and neonatal monitoring market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for fetal and neonatal monitoring market, research and consulting firms, new entrants, and financial analysts

Market Segmentation

• By Product Type (Revenue, USD Bn, 2021-2033)
  • Fetal Monitoring Devices
    • Heart Rate Monitors
    • Uterine Contraction Monitor
    • Pulse Oximeters
    • Others (Fetal ECG, Doppler, and Continuous Monitors)
  • Neonatal Monitoring Devices
    • Cardiac Monitors
    • Capnographs
    • Blood Pressure Monitors
    • Pulse Oximeters
    • Others (X-ray, CT scans, and MRI)
• By Portability (Revenue, USD Bn, 2021-2033)
  • Portable Monitoring Devices
  • Non-portable Monitoring Devices
• By Method (Revenue, USD Bn, 2021-2033)
  • Invasive Monitoring Devices
  • Non-invasive Monitoring Devices
• By End User (Revenue, USD Bn, 2021-2033)
  • Hospitals
  • Nursing Homes
  • Specialty Clinics
  • Ambulatory Surgery Centers
• By Region (Revenue, USD Bn, 2021-2033)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • Central Africa
    • North Africa
• Key Players
  • Becton, Dickinson and Company
  • Fujifilm SonoSite Inc.
  • Medtronic Plc
  • Dragerwerk AG & Co. KGAA
  • Cooper Surgical
  • Getinge AB
  • Natus Medical Incorporated
  • GE Healthcare
  • Siemens Healthcare GmbH
  • ArjoHuntleigh, Inc.
  • Neoventa Medical
  • Koninklijke Philips N.V.
  • Analogic Corporation
  • Spacelabs Healthcare Inc.
  • Smith Medical
  • Masimo